20 State AGs Put Top U.S. Pediatric Group On Notice for "Abusive" and "Experimental" Trans Therapy Guidance

Following the Cass report, the American Academy of Pediatrics is the latest to face for possible violations over its unscientific standards on gender dysphoria

“It is abusive to treat a child with biologically altering drugs that have an unknown physiological trajectory and end point. It is also inhumane to endorse such experimentation without a confident safety profile, especially if more times than not, it proves to be medically unnecessary.”

This statement unpins the tone of the legal notice signed by 20 state Attorneys General to the American Academy of Pediatrics (AAP) asking the group to answer to possible violations of state consumer protection statutes over its questionable standards on gender dysphoria care for minors.

"…the AAP continues to authoritatively declare that puberty blockers are ‘reversible,’" the letter continued. "That claim is scientifically unsupported and contradicts what is medically known. And because that claim raises questions under most state consumer protection laws, it has the undersigned alarmed" The letter goes on to state.

Idaho AG and co-signer of the action letter Raúl Labrador stated, “It is shameful the most basic tenet of medicine – do no harm – has been abandoned by professional associations when politically pressured,” said Attorney General Labrador. These organizations are sacrificing the health and well-being of children with medically unproven treatments that leave a wake of permanent damage.”

Why are these AGs acting now? The momentum has gained breakaway speed regarding the science of gender affirming care for minors.

Puberty blockers are not fully reversible and come with serious long-term consequences. According to the Cass Report commissioned by NHS England, using puberty blockers are used to suppress hormones during or before puberty can interfere with neurocognitive development, compromise bone density and may negatively affect metabolic health and weight.

And when puberty blocker use is followed directly by cross-sex hormone use, which is often the case, infertility and sterility is a known consequence.

The controversial world of gender care isn’t the only space that the AAP has dove into without an abundance of caution. The group made headlines in 2023 by radically altering their front line weight loss recommendations children ages 12 and up to include a new class of risky drugs and weight-loss surgery.

The AAP’s murky ‘science’ recommendations reached an early level of appalling shame in 2019 when, during a public hearing in 2019 to discuss an act before it was signed into law, pediatrician Dr. Helene Felman, representing Washington D.C.’s chapter of the American Academy of Pediatrics (AAP), stated:

“As a pediatrician, I like the legislation as it stands because it offers the opportunity to capture those young adults who can make informed decisions at technically any age.”

11 was ultimately decided upon until a federal court for the District of Columbia granted a preliminary injunction in a case funded by The Informed Consent Action Network.

The American Medical Association (AMA) had also thrown its full weight behind attempting to remove the parents from medical decisions involving their children.

Looking at where their energy has gone in key moments, one thing appears clear, the AAP wants children isolated from their parents and given over to the medical system for pharmaceutical interventions with known risk profiles. Why?